GLP-1 agonists: superior for mind and body in antipsychotic-treated patients?
Kateřina Horská, Jana Kučerová, Silje Skrede
Topics & Concepts
MedicineAdverse effectDyslipidemiaAntipsychoticDiabetes mellitusSchizophrenia (object-oriented programming)Metabolic syndromeBioinformaticsInternal medicinePharmacologyEndocrinologyPsychiatryBiologyDiabetes Treatment and ManagementPharmacology and Obesity TreatmentMetabolism, Diabetes, and Cancer